Abstract:Background The global coronavirus disease 2019 (COVID-19) pandemic seriously affected people's lives. We evaluated anxiety and depression among patients with insomnia in northeast China during the first wave and release of COVID-19, providing a basis for the clinical diagnosis and treatment of insomnia. Methods We enrolled 4211 patients with insomnia from January 2016 to February 2020, August 2020 to February 2022, August 2022 to December 2022, and January 2023 to February 2023, from our institution. Sleep quality was evaluated using the Athens Insomnia Scale, Insomnia Severity Index (ISI), and Pittsburgh sleep quality index (PSQI), while mood disorder and fatigue were evaluated using the Hhospital anxiety and depression scale (HAD), Patient Health Questionnaire-9 (PHQ-9), Generalized Anxiety Disorder (GAD-7), and Fatigue Scale-14 (FS-14). Results Insomnia with depression increased in prevalence after COVID-19 compared with before (12.8¬†% vs. 15.3¬†%, P ¬†<¬†0.05), while the age of patients decreased [(50.2¬†¬Ī¬†15.2) vs. (47.5¬†¬Ī¬†16.8), P ¬†<¬†0.05]. The number of patients with insomnia and severe depression increased compared with before COVID-19 (20.3¬†% vs. 25.3¬†%, P ¬† 2¬†years had depression ( P ¬†<¬†0.05). As the epidemic subsided, insomnia increased among young and male patients (young patients: 55.2¬†% vs. 37.0¬†%; male patients: 41¬†% vs. 27.4¬†%, respectively; P ¬†<¬†0.05). The proportion of patients with insomnia with anxiety and depression increased (53.8¬†% vs. 51.8¬†%, P ¬†<¬†0.05), the proportion with moderate to severe anxiety increased (7.6¬†% vs. 13.5¬†%, P ¬†<¬†0.05), and moderate and severe depression decreased (moderate: 25.6¬†% vs. 19.1¬†%, severe: 25.8¬†% vs. 20.3¬†%, P ¬†<¬†0.05, respectively). Middle-aged and elderly patients had higher PQSI scores in sleep latency, habitual sleep efficiency, subjective sleep quality, and use of sleep medications than young patients ( P ¬†<¬†0.05). The PSQI score was positively correlated with the PHQ-9 score ( r ¬†=¬†0.526), GAD-7 score ( r ¬†=¬†0.563), and FS-14 score ( r ¬†=¬†0.316) ( P ¬†<¬†0.05). Limitations The study was single-center, the sample size was small, and assessment data were lacking from early in the epidemic. The scale is subjective, which may affect the accuracy. Conclusion Insomnia with depression increased during COVID-19. The patients were younger than before the epidemic, and a higher proportion with insomnia for >2¬†years had depression. The proportion of patients with insomnia with anxiety and depression was higher after the epidemic period, and the degree worsened. The proportion of insomnia with depression decreased after the epidemic period, and the degree alleviated. The proportion of young male patients with insomnia increased. Middle aged and elderly patients with insomnia had poor sleep quality, which was positively correlated with anxiety, depression, and fatigue.

The associations among the stress symptoms, depressive symptoms, anxiety symptoms and insomnia symptoms in depressed patients after the first COVID-19 outbreak was initially controlled in China: A prospective cohort study

Insomnia mediates the effect of perceived stress on emotional symptoms during the first wave of the COVID-19 pandemic in China

Prevalence of psychological disorders in the COVID-19 epidemic in China: A real world cross-sectional study

Status and influential factors of anxiety depression and insomnia symptoms in the work resumption period of COVID-19 epidemic: A multicenter cross-sectional study

Anxiety and depression among patients with insomnia during the first wave and the release of the COVID-19 in Northeast China: A cross-sectional survey

Mental Health Status and Related Influencing Factors in Patients with COVID-19.

COVID-19 pandemic related long-term chronic stress on the prevalence of depression and anxiety in the general population

Longitudinal study of mental health changes in residents affected by an initial outbreak of COVID-19 in China

Prevalence of depressive symptoms and correlates among individuals who self-reported SARS-CoV-2 infection after optimizing the COVID-19 response in China

Anxiety, depression, insomnia symptoms & associated factors among young to middle-aged adults during the resurgent epidemic of COVID-19: a cross-sectional study

Psychological impact on COVID-19 patients during the outbreak in China: A case-control study

The immediate impact of the 2019 novel coronavirus (COVID-19) outbreak on subjective sleep status

Depressive, anxiety, and insomnia symptoms between population in quarantine and general population during the COVID-19 pandemic: a case-controlled study

Associations Between Poor Sleep Quality, Anxiety Symptoms, and Depressive Symptoms Among Chinese Adolescents Before and During COVID-19: A Longitudinal Study

Long-Term Impact of COVID-19 on Mental Health among the General Public: A Nationwide Longitudinal Study in China

Changes in the mental health status of the general Chinese population during the COVID-19 pandemic: A longitudinal study

Association of insomnia disorder with sociodemographic factors and poor mental health in COVID-19 inpatients in China

Insomnia, Anxiety, and Depression During the COVID-19 Pandemic: an International Collaborative Study

Epidemiology of Sleep Disturbances and Their Effect on Psychological Distress During the COVID-19 Outbreak: A Large National Study in China

Immediate Psychological Responses and Associated Factors during the Initial Stage of the 2019 Coronavirus Disease (COVID-19) Epidemic among the General Population in China

Psychological distress and sleep quality of COVID-19 patients in Wuhan, a lockdown city as the epicenter of COVID-19